First published 10/3/2026, 7:57:15 PM · Last updated 10/3/2026, 7:57:15 PM

Determination of benazepril HCl and hydrochlorothiazide in pharmaceutical preparations using UV-visible spectrophotometry and genetic multivariate calibration method

A journal article reports an analytical method to measure benazepril HCl and hydrochlorothiazide in pharmaceutical preparations using UV-visible spectrophotometry combined with a genetic multivariate calibration method. The item is published by the Journal of Food and Drug Analysis and associated with the Taiwan Food and Drug Administration.

Illustrative image: Spectrophotometer cuvettes: quartz (UV) and plastic (visible) — Retama/Wikimedia Commons, CC BY-SA 4.0

Categories: science-and-space

Generated scores

Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.

Confidence: 6/10How certain the assessment is based on the clarity and evidence in the cited reporting.
Geographic reach: 2/10How widely the event reaches, from a local area (1) to worldwide impact (10).
Global importance: 3/10The event's broader significance, from limited importance (1) to major global importance (10).
Impact magnitude: 3/10The scale or severity of the real-world impact, from minor (1) to extreme (10).
Positivity: 6/10How harmful or beneficial the event is, from strongly harmful (1) to strongly positive (10).
Urgency: 1/10How time-sensitive the event is, from low urgency (1) to immediate attention needed (10).

Why it matters

Describes a laboratory analytical approach relevant to pharmaceutical quality control for two antihypertensive drugs.

Sources

Determination of benazepril HCl and hydrochlorothiazide in pharmaceutical preparations using UV-visible spectrophotometry and genetic multivariate calibration methodMetadata provided by Crossref. Usage terms

Report an issue